SPRC

NASDAQ 已收盘

SciSparc

0.20 USD
▼-0.10-34.83%
盘后 0.18 -6.39%
2026-11-20
市值
$481.60K
市盈率
—
EPS
-22.11
股息率
—
52 周区间
0.17 – 29.88
成交量
4.66M
Beta
2.66
目标价
—
52W 低 0.1752W 高 29.88
价格走势

公司简介

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer’s disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company sells hemp seed oil-based products and others. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and palmitoylethanolamide oral ta...

关联新闻